A massive study of ovarian cancer screening has determined that annual screening with ultrasound alone or CA125 testing and, if necessary, follow-up with ultrasound does not reduce mortality in the general population. Although more early cases came to light with screening, the increase was not large enough to yield a statistically significant survival improvement.